This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WARREN T. SUTTON, MD; FORD VAN HAGEN, MD; B. HEROLD GRIFFITH, MD; FREDERICK W. PRESTON, MD

AMA Arch Surg. 1963;87(5):840-843.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Many attempts have been made to prolong the survival of homografts by suppressing the reticuloendothelial system of the host with drugs and other agents. A study of the Bagg lymphosarcoma in our laboratory showed that the growth of homografts of this tumor in rats was enhanced when the recipient animals were preconditioned with certain cytotoxic drugs and antimetabolites.⁴ This study has been extended to determine if these agents affect the survival of homograft of normal skin. The transparent chamber technique was used because it provides an accurate criteria of survival of homografts. Skin is an organ which is very sensitive to the homograft rejection mechanism. Drugs which affect the survival of homografts of skin might have a similar effect upon homografts of other tissues. It is hoped that the simple technique described in this paper might be useful in the selection of drugs for the conditioning of animals for . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Surgery, Veterans Administration Research Hospital and Northwestern University Medical School.

Footnotes
Submitted for publication May 21, 1963.

Aided by grants from the United Fund of Northfield Illinois, Inc., and from the Illinois Division of the American Cancer Society.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?